12:00 AM
Jun 11, 2012
 |  BC Week In Review  |  Company News  |  Deals

Foundation Medicine, Novartis deal

The companies expanded a 2011 pilot program to analyze the genomes of cancer patients' tumors enrolled in trials of the pharma's products. Under the...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >